Arrow
Arrow
Slider

Przed STREAM

  1. Dudek-Peric AM, Ferreira GB, Muchowicz A, Wouters J, Prada N, Matrin S, Kiviluoto S, Winiarska M, Boon L, Mathieu C, van den Oord J, Stas M, Gougeon ML, Golab J, Garg AD, Agostinis P. Anti-tumor immunity triggered by melphalan is potentiated by melanoma cell surface associated calreticulin. Cancer Res 2015; 75: 1603-1614.
    http://www.ncbi.nlm.nih.gov/pubmed/25762540 
  2. Bojarczuk K, Siernicka M, Dwojak M, Bobrowicz M, Pyrzynska B, Gaj P, Karp M, Giannopoulos K, Efremov DG, Fauriat C, Golab J, Winiarska M. B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies. Leukemia. 2014; 28: 1163-1167.
    http://www.ncbi.nlm.nih.gov/pubmed/24492323 
  3. Wachowska M, Gabrysiak M, Muchowicz A, Bednarek W, Barankiewicz J, Rygiel T, Boon L, Mroz P, Hamblin MR, Golab J. 5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy. Eur J Cancer 2014; 50: 1370-1381.
    http://www.ncbi.nlm.nih.gov/pubmed/24559534 
  4. Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ 2014; 21: 26-38.
    http://www.ncbi.nlm.nih.gov/pubmed/23686135 
  5. Firczuk M, Gabrysiak M, Barankiewicz J, Domagala A, Nowis D, Kujawa M, Jankowska-Steifer E, Wachowska M, Glodkowska-Mrowka E, Korsak B, Winiarska M, Golab J. GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. Cell Death Dis 2013; 4: e741.
    http://www.ncbi.nlm.nih.gov/pubmed/23887632 
  6. Winiarska M, Nowis D, Bil J, Glodkowska-Mrowka E, Muchowicz A, Wanczyk M, Bojarczuk K, Dwojak M, Firczuk M, Wilczek E, Wachowska M, Roszczenko K, Miaczynska M, Chlebowska J, Basak GW, Golab J. Prenyl transferases regulate CD20 levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity. J Biol Chem 2012; 287: 31983-31993.
    http://www.ncbi.nlm.nih.gov/pubmed/22843692 
  7. Malenda A, Skrobanska A, Issat T, Winiarska M, Bil J, Oleszczak B, Sinski M, Firczuk M, Bujnicki JM, Chlebowska J, Staruch AD, Glodkowska-Mrowka E, Kunikowska J, Krolicki L, Szablewski L, Gaciong Z, Koziak K, Jakobisiak M, Golab J, Nowis DA. Statins impair glucose uptake in tumor cells. Neoplasia 2012; 14: 311-323.
    http://www.ncbi.nlm.nih.gov/pubmed/22577346 
  8. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJM, Annaert W, Golab J, de Witte P, Vandenabeele P, Agostinis P. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012; 31: 1062-1079.
    http://www.ncbi.nlm.nih.gov/pubmed/22252128 
  9. Klossowski S, Muchowicz A, Firczuk M, Świech M, Redzej A, Golab J, Ostaszewski R. Studies towards novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system. J Med Chem 2012; 55: 55-67.  
    http://www.ncbi.nlm.nih.gov/pubmed/22128876 
  10. Agostinis P, Berg K, Foster TH, Girotti AW, Gollnick SO, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update CA: A Cancer J Clin 2011; 61: 250-281.
    http://www.ncbi.nlm.nih.gov/pubmed/21617154 
  11. Jakobisiak M, Golab J, Lasek W. Interleukin 15 as a promising candidate for tumor immunotherapy. Cytokine Growth Factors Rev 2011; 22: 99-108.
    http://www.ncbi.nlm.nih.gov/pubmed/21531164 
  12. Bil J, Winiarska M, Nowis D, Bojarczuk K, Dabrowska-Iwanicka A, Basak GW, Sulek K, Marek J, Golab J. Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity. Blood 2010; 115: 3745-3755.
    http://www.ncbi.nlm.nih.gov/pubmed/20200358 
  13. Nowis D, Maczewski M, Mackiewicz U, Kujawa M, Ratajska A, Wieckowski M, Wilczynski GM, Malinowska M, Bil J, Salwa P, Bugajski M, Wojcik C, Sinski M, Abramczyk P, Winiarska M, Dabrowska-Iwanickab A, Duszynski J, Jakobisiak M, Golab J. Cardiotoxicity of the anticancer therapeutic agent bortezomib. Am J Pathol 2010; 176: 2658-2668.
    http://www.ncbi.nlm.nih.gov/pubmed/20519734 
  14. Mroczkiewicz M, Winkler K, Nowis D, Placha G, Golab J, Ostaszewski R. Studies of the synthesis of all stereoisomers of MG-132 proteasome inhibitors in the tumor targeting approach. J Med Chem 2010; 53: 1509-1518.
    http://www.ncbi.nlm.nih.gov/pubmed/20112914 
  15. Szokalska A, Makowski M, Nowis D, Wilczynski GM, Kujawa M, Wojcik C, Mlynarczuk-Bialy I, Salwa P, Bil J, Janowska S, Agostinis P, Verfaillie T, Bugajski M, Gietka J, Issat T, Glodkowska E, Mrowka P, Stoklosa T, Hamblin MR, Mroz P, Jakobisiak M, Golab J. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of ER stress and unfolded protein response. Cancer Res 2009; 69: 4235-4243.
    http://www.ncbi.nlm.nih.gov/pubmed/19435917 
  16. Winiarska M, Bil J, Wilczek E, Wilczynski GM, Lekka M, Engelberts PJ, Mackus WJ, Gorska E, Bojarski L, Stoklosa T, Nowis D, Kurzaj Z, Makowski M, Glodkowska E, Issat T, Mrowka P, Lasek W, Dabrowska-Iwanicka A, Basak GW, Wasik M, Warzocha K, Sinski M, Gaciong Z, Jakobisiak M, Parren PW, Golab J. Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med 2008; 5: e64 (502-517).
    http://www.ncbi.nlm.nih.gov/pubmed/18366248 
  17. Mlynarczuk-Bialy I, Roeckmann H, Kuckelkorn U, Schmidt B, Umbreen S, Golab J, Ludwig A, Montag C, Wiebusch L, Hagemeier C, Schadendorf D, Kloetzel P.M., Seifert U. Combined effect of proteasome and calpain inhibition on cisplatin resistant human melanoma cells. Cancer Res 2006; 66: 4598-7605.
    http://www.ncbi.nlm.nih.gov/pubmed/16885359 
  18. Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Waś H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, Golab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006; 25: 3365-3374.
    http://www.ncbi.nlm.nih.gov/pubmed/16462769 
  19. Jalili A, Makowski M, Świtaj T, Nowis N, Wilczynski GM, Wilczek E, Choraay-Massalska M, Radzikowska A, Maślinski W, Bialy L, Sienko J, Sieron A, Adamek M, Basak G, Mroz P, Krasnodębski IW, Jakobisiak M, Golab J. Effective photoimmunotherapy of murine colon carcinoma induced by the combinationn of photodynamic therapy and dendritic cells. Clin Cancer Res 2004; 10: 4498-4508.
    http://www.ncbi.nlm.nih.gov/pubmed/15240542 
  20. Świtaj T, Jalili A, Jakubowska AB, Drela N, Stoksik M, Nowis D, Basak G, Golab J, Wysocki PJ, Mackiewicz A, Sasor A, Socha-Urbanek K, Jakobisiak M, Lasek W. CpG immunostimulatory oligodeoxynucleotide (ODN) 1826 enhances antitumor effec of IL-12 gene-modified vaccine in a melanoma model in mice. Clin Cancer Res 2004; 10: 4165-4175.
    http://www.ncbi.nlm.nih.gov/pubmed/15217954 
  21. Makowski M, Grzela T, Niderla J, Lazarczyk M, Mroz P, Kopeć M, Legat M, Strusinska K, Koziak K, Nowis D, Mrowka P, Wasik M, Jakobisiak M, Golab J. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin Cancer Res 2003; 9: 5417-5422.
    http://www.ncbi.nlm.nih.gov/pubmed/14614028 
  22. Kozar K, Kaminski R, Świtaj T, Oldak T, Machaj E, Wysocki PJ, Mackiewicz A, Jakobisiak M, Golab J. Interleukin 12 based immunotherapy improves the antitumor effectiveness of a low-dose 5-aza-2‘-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Clin Cancer Res 2003; 9: 3124-3133.
    http://www.ncbi.nlm.nih.gov/pubmed/12912964 
  23. Golab J, Nowis D, Skrzycki M, Czeczot H, Anna Baranczyk-Kuzma A, Wilczynski GM, Makowski M, Mroz P, Kozar K, Kaminski R, Jalili A, Kopeć M, Grzela T, Jakobisiak M. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol - a superoxide dismutase inhibitor. J Biol Chem. 2003; 278: 407-414.
    http://www.ncbi.nlm.nih.gov/pubmed/12409296 
  24. Golab J, Olszewska D, Mroz P, Kozar K, Kaminski R, Jalili A, Jakobisiak M. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res 2002; 8: 1265-1270.
    http://www.ncbi.nlm.nih.gov/pubmed/12006547
  25. Golab J, Zagoadaon R, Kaminski R, Kozar K, Gryska K, Iaycki D, Mackiewicz A, Stoklosa T, Giermasz A, Lasek W, Jakobisiak M. Potentiatied antitumor effectiveness of combined immuno-chemotherapy with interleukin-12 and 5-Fluorouracil of L1210 leukemia in vivo. Leukemia 2001; 15: 613-620.
    http://www.ncbi.nlm.nih.gov/pubmed/11368364 
OPEN